References
- Adeva-Andany MM, Ameneiros-Rodriguez E, Fernandez-Fernandez C, Dominguez-Montero A, Funcasta-Calderon R. Insulin resistance is associated with subclinical vascular disease in humans. World J Diabetes 10, 63–77, 2019.10.4239/wjd.v10.i2.63637973230788044
- American Diabetes Association. Standards of medical care in diabetes-2017. Diabetes Care 40, 88–98, 2017.10.2337/dc17-er07c548197428522554
- Ansar H, Mazloom Z, Kazemi F, Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance, and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 32, 584–588, 2011.
- Balcioglu AS, Muderrisoglu H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes 6, 80–89, 2015.10.4239/wjd.v6.i1.80431732025685280
- Boghdadi MA, Afify HE, Sabri N, Makboul K, Elmazar M. Comparative study of vitamin B complex combined with alpha lipoic acid versus vitamin B complex in the treatment of diabetic polyneuropathy in type 2 diabetic patients. Clin Exp Pharmacol 7, 241, 2017.
- Chorepsima S, Eleftheriadou I, Tentolouris A, Moyssakis I, Protogerou A, Kokkinos A, Sfikakis PP, Tentolouris N. Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus. BMC Endocr Disord 17, 27, 2017.10.1186/s12902-017-0178-2543853028526073
- Colussi G, Catena C, Novello M, Bertin N, Sechi LA. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes. Nutr Metab Cardiovasc Dis 27, 191–200, 2017.10.1016/j.numecd.2016.07.01127692558
- Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, Frontoni S. Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 34, 1605–1609, 2011.10.2337/dc11-0034312019821610126
- Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 5, 17–39, 2014.10.4239/wjd.v5.i1.17393242524567799
- Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, Izumotani K, Shoji T, Ishimura E, Inaba M, Okuno Y, Morii H. Stiffness indexes β of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 21, 1178–1182, 1998.10.2337/diacare.21.7.11789653616
- Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8, 491–498, 1985.10.2337/diacare.8.5.4914053936
- Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, Ceriello A. Glucose variability: An emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract, 102, 86–95, 2013.10.1016/j.diabres.2013.09.00724128999
- Golbidi S, Badran M, Laher I. Diabetes and alpha lipoic acid. Front Pharmacol 2, 69, 2011.10.3389/fphar.2011.00069
- Gomes MB, Negrato CA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab Syndr 6, 80, 2014.10.1186/1758-5996-6-80
- Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress. Oxid Med Cell Longer 2013, 168039, 2013.10.1155/2013/168039
- Huikuri HV, Makikallio TH. Heart rate variability in ischemic heart disease. Auton Neurosci 90, 95–101, 2001.10.1016/S1566-0702(01)00273-9
- Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittel-Forsch 45, 872–874, 1995.
- Jacob S, Ruus P, Hermann R, Ritschler HJT, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of RAC-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27, 309–314, 1999.10.1016/S0891-5849(99)00089-1
- Koumaras C, Katsiki N, Athyros VG, Karagiannis A. Metabolic syndrome and arterial stiffness: the past, the present and the future. J Cardiovasc Med (Hagerstown) 14, 687–689, 2013.10.2459/JCM.0b013e3283657c9624335882
- La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT, Camm AJ, Schwartz PJ; ATRAMI Investigators. Autonomic tone and reflexes after myocardial infarction. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103, 2072–2077, 2001.10.1161/01.CIR.103.16.207211319197
- Lal C, Kaur M, Jaryal AK, Deepak KK, Bhowmik D, Agarwal SK. Reduced baroreflex sensitivity, decreased heart rate variability with increased arterial stiffness in predialysis. Indian J Nephrol 27, 446–451, 2017.10.4103/ijn.IJN_63_17570440929217881
- Lee SJ, Jeong SJ, Lee YC, Lee YH, Lee JE, Kim CH, Min KW, Cha BY. Effects of high-dose α-lipoic acid on heart rate variability of type 2 diabetes mellitus patients with cardiac autonomic neuropathy in Korea. Diabetes Metab J 41, 275–283, 2017.10.4093/dmj.2017.41.4.275558340528868825
- Liatis S, Alexiadou K, Tsiakou A, Makrilakis K, Katsilambros N, Tentolouris N. Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res 2011, 957901, 2011.10.1155/2011/957901314345421804819
- MacFadyen RJ, Lim HS. Emergence of structural arterial stiffness in diabetes and the role of abnormalities of autonomic tone in the sequence of events. J Hum Hypertens 18, 755–756, 2004.10.1038/sj.jhh.100175515254562
- Manrique C, Lastra G, Sowers JR. New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci 1311, 138–150, 2014.10.1111/nyas.12395398983824650277
- Mansour AS, Yannoutsos A, Majahalme N, Agnoletti D, Safar ME, Ouerdane S, Blacher J. Aortic stiffness and cardiovascular risk in type 2 diabetes. J Hypertens 31, 1584–1592, 2013.10.1097/HJH.0b013e328361307423822928
- Markus MRP, Rospleszcz S, Ittermann T, Baumeister SE, Schipf S, Siewert-Markus U, Lorbeer R, Storz C, Ptushkina V, Peters A, Meisinger C, Bamberg F, Nauck M, Bahls M, Volzke H, Burkhard Felix S, Bulow R, Rathmann W, Dorr M. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart. Cardiovasc Diabetol 18, 145, 2019.10.1186/s12933-019-0948-4682993431684945
- Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes a meta-analysis. Diabetes Care 26, 1895–1901, 2003.10.2337/diacare.26.6.189512766130
- Mattace-Raso FU, van den Meiracker AH, Bos WJ, van der Cammen TJ, Westerholf BE, Elias-Smale S, Reneman RS, Hoeks AP, Hofman A, Witteman JC. Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study. J Hypertens 25, 1421–1426, 2007.10.1097/HJH.0b013e32811d6a0717563564
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419, 1985.10.1007/BF002808833899825
- Morioka T, Mori K, Emoto M. Is stiffness parameter β useful for the evaluation of atherosclerosis? ~ Its clinical implications, limitations, and future perspectives. J Atheroscler Thromb 28, 435–453, 2021.10.5551/jat.RV17047819378833583910
- Olsen MH, Fossum E, Hjerkinn E, Wachtell K, Hoieggen A, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S. Relative influence of insulin resistance vs blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE substudy. Insulin Carotids US Scandinavia. J Hypertens 18, 75–81, 2000.10.1097/00004872-200018010-0001110678546
- Pop Busui R, Stevens MJ, Raffel DM, White EA, Mehta M, Plunkett CD, Brown MB, Feldman EL. Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomized controlled trial. Diabetologia 56, 1835–1844, 2013.10.1007/s00125-013-2942-9373082823740194
- Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 40, 136–154, 2017.10.2337/dc16-2042697740527999003
- Ramamurthy S, Ronnet G. AMP-activated protein kinase (AMPK) and energy sensing in the brain. Exp Neurobiol 21, 52–60, 2012.10.5607/en.2012.21.2.52338121222792025
- Scaramuzza A, Giani E, Redaelli F, Ungheri S, Macedoni M, Giudici V, Bosetti A, Ferrari M, Zuccotti GV. Alpha-lipoic acid and antioxidant diet help to improve endothelial dysfunction in adolescents with type 1 diabetes: A Pilot Trial. J Diabetes Res 2015, 474561, 2015.10.1155/2015/474561447838226171398
- Sengstock DM, Vaitkevicius PV, Supiano MA. Arterial stiffness is related to insulin resistance in nondiabetic hyper-tensive older adults. J Clin Endocrinol Metab 90, 2823–2827, 2005.10.1210/jc.2004-168615728211
- Serhiyenko VA, Serhiyenko AA. Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? World J Diabetes 6, 245–258, 2015.10.4239/wjd.v6.i2.245436041825789106
- Serhiyenko VA, Serhiyenko AA. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World J Diabetes 9, 1–24, 2018.10.4239/wjd.v9.i1.1576303629359025
- Serhiyenko V, Serhiyenko L, Krasnyi M, Serhiyenko A. Alpha-lipoic acid: therapeutic potential in diabetic neuropathies. Curre Res Diabetes Obes J 7, 555713, 2018.10.19080/CRDOJ.2018.07.555713
- Sessa F, Anna V, Messina G, Cibelli G, Monda V, Marsala G, Ruberto M, Biondi A, Cascio O, Bertozzi G, Pisanelli D, Maglietta F, Messina A, Mollica MP, Salerno M. Heart rate variability as predictive factor for sudden cardiac death. Aging (Albany NY), 10, 166–177, 2018.10.18632/aging.101386584285129476045
- Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790, 1149–1160, 2009.10.1016/j.bbagen.2009.07.026275629819664690
- Sleight P, La Rovere MT, Mortara A, Pinna G, Maestri R, Leuzzi S, Bianchini B, Tavazzi L, Bernardi L. Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci 99, 103–109, 1995.10.1042/cs08801037677832
- Soares-Miranda L, Sandercock G, Vale S, Santos R, Abreu S, Moreira C, Mota J. Metabolic syndrome, physical activity and cardiac autonomic function. Diabetes Metab Res Rev 28, 363–369, 2012.10.1002/dmrr.228122238216
- Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27, 639–653, 2011.10.1002/dmrr.123921695768
- Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 51, 527–539, 2008.10.1007/s00125-007-0918-318239908
- Tandon N, Ali MK, Narayan KM. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes. Am J Cardiovasc Drugs 12, 7–22, 2012.10.2165/11594650-000000000-0000022217193
- TensioClinicTensioMed™ Arteriograph and TensioMed™ program. Available from: http://www.arteriograph.nl/?act=download&fid=173.
- Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293, 2010.10.2337/dc10-1303294517620876709
- Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, Shiina K, Yamamoto Y, Yamashina A. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 47, 180–188, 2006.10.1161/01.HYP.0000198539.34501.1a16380535
- Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroff JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T; American Heart Association Council on Hypertension. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension 66, 698–722, 2015.10.1161/HYP.0000000000000033458766126160955
- Vallianou N, Evangelopoulos A, Koutalas P. Alpha-lipoic acid and diabetic neuropathy. Rev Diabet Stud 6, 230–236, 2009.10.1900/RDS.2009.6.230283619420043035
- van Dijk RA, Bakker SJ, Scheffer PG, Heine RJ, Stehouwer CD. Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Invest 33, 307–315, 2003.10.1046/j.1365-2362.2003.01137.x12662161
- Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne) 5, 205, 2014.10.3389/fendo.2014.00205424949225520703
- Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol 17, 279–294, 2013.10.1016/B978-0-444-53491-0.00022-524095132
- Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig 4, 4–18, 2013.10.1111/jdi.12042358088423550085
- Vinik AI, Casellini C, Parson HK, Colberg SR, Nevoret ML. Cardiac autonomic neuropathy in diabetes: A predictor of cardiometabolic events. Front Neurosci 12, 591, 2018.10.3389/fnins.2018.00591611972430210276
- Wang Y, Li X, Guo Y, Chan L, Guan X. Alpha-lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1 alpha signaling in the skeletal muscle of aged mice. Metabolism 59, 967–976, 2010.10.1016/j.metabol.2009.10.018288250920015518
- Yki-Jarvinen H, Westerbacka J. Insulin resistance, arterial stiffness and wave reflection. Adv Cardiol 44, 252–260, 2007.10.1159/00009674617075214
- Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20, 369–373, 1997.10.2337/diacare.20.3.3699051389
- Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, Samigullin R, Tritschler H, Munzel U, Maus J, Schutte K, Dyck PJ. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34, 2054–2060, 2011.10.2337/dc11-0503316130121775755
- Ziegler D, Keller J, Maier C, Pannek J; German Diabetes Association. Diabetic neuropathy. Exp Clin Endocrinol Diabetes 122, 406–415, 2014.10.1055/s-0034-136643525014092